Date published: 2025-10-8

1-800-457-3801

SCBT Portrait Logo
Seach Input

Dorzolamide maleic acid adduct

0.0(0)
Write a reviewAsk a question

Alternate Names:
2-(Ethyl((4S,6S)-6-methyl-7,7-dioxido-2-sulfamoyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-4-yl)amino)succinic Acid
Molecular Weight:
440.51
Molecular Formula:
C14H20N2O8S3
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Dorzolamide maleic acid adduct is a carbonic anhydrase inhibitor that functions by binding to the enzyme and inhibiting its activity. This adduct targets the carbonic anhydrase enzyme in the ciliary processes of the eye, reducing the production of aqueous humor and subsequently lowering intraocular pressure. The mechanism of action involves the adduct binding to the active site of the enzyme, preventing the conversion of carbon dioxide and water to bicarbonate and protons. This inhibition ultimately leads to a reduction in the secretion of aqueous humor, which may be useful for studying the regulation of intraocular pressure in experimental models. The adduct′s mechanism of action at the molecular level provides insights into the physiological processes involved in aqueous humor production and the potential for developing novel experimental approaches for studying ocular conditions.

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Dorzolamide maleic acid adduct, 2.5 mg

sc-495894
2.5 mg
$393.00